Status:
COMPLETED
Follow-up of Post-spinal Implantable Neurostimulator PRECISION®
Lead Sponsor:
Cemka-Eval
Collaborating Sponsors:
Boston Scientific Corporation
Conditions:
Chronic Refractory Neuropathic Pain
Ischemic Peripheral Pain
Eligibility:
All Genders
18+ years
Brief Summary
Assessing the long-term efficacy, complications, revision rates and final explantation of the device
Detailed Description
Longitudinal study with a follow-up of 2 years in patients implanted with the Precision neurostimulator. This study will describe the characterisrics of the patients, of the implantation and will ass...
Eligibility Criteria
Inclusion
- Adult patient receiving spinal implantation of a neurostimulator PRECISION ® ( primary implantation or reimplantation)
Exclusion
- Refusal of patient
- Patient whose long-term monitoring will not be possible
Key Trial Info
Start Date :
December 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT02208999
Start Date
December 1 2013
End Date
December 1 2017
Last Update
November 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospitals implanting the neurostimulator Precision
Multiple Locations, France